EDITION:

Search
Search
Close this search box.

British cannabis firm Avida Global strengthens team to drive seed to sale strategy

British cannabis firm Avida Global has appointed medical cannabis expert Heidi Whitman to drive its seed to sales strategy.

The British producer of high-quality medicinal cannabis oils, has announced the appointment of Heidi Whitman as global strategy director. 

In this newly created role, Heidi will be responsible for driving Avida Global’s strategy of becoming a vertically integrated seed to sales business, serving the global medical and consumer well-being markets. 

Heidi has worked within the medicinal cannabis space for the last four years. 

Heidi Whitman, global strategy director, Avida Global

Most recently, she utilised her technical background in the veterinary industry to co-found a brand called Naked Leaf, formulating CBD products for people and animals, which were sold online and via a network of distributors in the US, UK, EU and Australasia. 

Naked Leaf and its parent company, CBD Labs LLC Ltd, were acquired by The House of Green in April 2019.

“The incredible advisory team at Avida Global and the company’s unique cultivating and manufacturing processes, were key in my decision to join,” said Whitman.

“I look forward to working closely with the team to propel Avida Global onto the global stage, leveraging its reputation for quality and consistency, to cultivate a seed to sales operation for customised medicinal and OTC cannabidiol products.”

Heidi will report directly to David Kirby, CEO.

Kirby added: “Our goal has always been to build a company that is synonymous with high-quality medicinal cannabis oils and products from plant to end user. Heidi’s deep expertise in the medicinal cannabis space will be key as we further our plans of becoming a leading global vertically integrated business serving the medical and consumer well-being markets.”

Avida Global is currently fundraising via Seedrs and has already overfunded its £1 million target by more than 137 percent. 

Based on a pre-money valuation of £15.5mn, Avida Global has currently secured £1,376,731 from 486 investors with 13 days left to go before the round closes. 

This is Avida Global’s first crowdfunding campaign having already raised more than £6.1million to date.

 

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?